(资料图片)
纳斯达克生物科技指数收跌超0.9%,成分股Immuneering跌超17.3%表现最差,Prelude、Xeris Pharmaceuticals、Terns Pharmaceuticals、Wave Life Sciences、Prothena Plc.、Roivant Sciences、Ventyx Biosciences至多收跌将近16.9%,Poseida Therapeutics Inc.和奥麦罗制药(OMER)则至多收涨超9.7%,和黄医药(HCM)涨超10.8%,Adaptimmune Therapeutics涨约14.4%,Summit Therapeutics Plc.涨超17.6%,Aurinia Pharmaceuticals涨37.5%